Rewriting Heart Health: Epigenetic Drugs in Cardiovascular Medicine.

Atzemian N, Di Venanzio L, Mohammed SA, Costantino S, Ruschitzka F, Paneni F

Open source

DOI
10.1093/ehjcvp/pvag075
Published
2026 Sep 24
Container
European heart journal. Cardiovascular pharmacotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvag075,
  title = {Rewriting Heart Health: Epigenetic Drugs in Cardiovascular Medicine.},
  author = {Atzemian N and Di Venanzio L and Mohammed SA and Costantino S and Ruschitzka F and Paneni F},
  year = {2026},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvag075},
  url = {https://doi.org/10.1093/ehjcvp/pvag075}
}

RIS

TY  - JOUR
TI  - Rewriting Heart Health: Epigenetic Drugs in Cardiovascular Medicine.
AU  - Atzemian N
AU  - Di Venanzio L
AU  - Mohammed SA
AU  - Costantino S
AU  - Ruschitzka F
AU  - Paneni F
PY  - 2026
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvag075
UR  - https://doi.org/10.1093/ehjcvp/pvag075
ER  - 

APA

N, A., L, D. V., SA, M., S, C., F, R., & F, P. (2026). Rewriting Heart Health: Epigenetic Drugs in Cardiovascular Medicine.. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvag075

Source records